Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:03:41.414Z.
Calculation as of: 2026-10-06T16:03:41.414Z.
Quote observation: 2026-10-06T16:00:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 44fde230bfdd574c3cd4cd53b0628620ec84ec898484da9a9f15813d4ff0e801
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
OrthoPediatrics Corp.
Market Cap
$587.06M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$593.86M
Free Cash Flow Yield
N/A
TTM Avg
2.13%
3Y Avg
14.68%
5Y Avg
12.04%
Market Cap
$600.84M
Free Cash Flow Yield
30.88%
TTM Avg
16.53%
3Y Avg
24.36%
5Y Avg
19.94%
Market Cap
$573.38M
Free Cash Flow Yield
N/A
TTM Avg
7.20%
3Y Avg
7.20%
5Y Avg
7.20%
Market Cap
$569.16M
Free Cash Flow Yield
N/A
TTM Avg
3.48%
3Y Avg
3.86%
5Y Avg
13.58%
Market Cap
$609.48M
Free Cash Flow Yield
0.08%
TTM Avg
0.21%
3Y Avg
0.21%
5Y Avg
0.70%
Market Cap
$566.81M
Free Cash Flow Yield
44.15%
TTM Avg
19.72%
3Y Avg
17.48%
5Y Avg
17.48%
Market Cap
$560.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.85M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $587.06M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.86M | N/A | 2.13% | 14.68% | 12.04% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 30.88% | 16.53% | 24.36% | 19.94% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | N/A | 7.20% | 7.20% | 7.20% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $569.16M | N/A | 3.48% | 3.86% | 13.58% |
| AngioDynamics, Inc. (ANGO)vs › | $609.48M | 0.08% | 0.21% | 0.21% | 0.70% |
| CorMedix Inc. (CRMD)vs › | $566.81M | 44.15% | 19.72% | 17.48% | 17.48% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $554.85M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $552.89M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
